CLINICAL_TRIALS
trial_result
· 2023-01-31
Clinical Trial Update: Crossover Trial of AD109 in Obstructive Sleep Apnea [Phase 2]
Summary
Phase 2 crossover trial of AD109 in obstructive sleep apnea has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Apnimed | Conditions: Obstructive Sleep Apnea | Phase 2 | Status: COMPLETED | Results posted: 2023-01-31